The flexible endoscope market is entering a golden period of development

Endoscopes represent a multi-billion dollar blue ocean market within the medical device sector, characterized by low domestic production rates and significant future growth potential. In recent years, the endoscope market has expanded continuously, with domestic manufacturers emerging strongly, including Auhua Endoscopy, the leading domestic vendor of flexible endoscopes.

The flexible endoscope market is entering a golden period of development.

Flexible endoscopes perform examinations, diagnoses, and treatments through the body's natural cavities, primarily in the digestive tract, such as gastroscopy and colonoscopy.

Influenced by dietary habits and environmental factors, China has a high incidence of digestive system tumors. According to data from the National Cancer Center, 3.93 million new malignant tumors were reported in China in 2015,with stomach cancer, colorectal cancer, and esophageal cancer accounting for 1,036,200 cases, or 26.37% of the total.

The only way to prevent and treat cancer is through "three early" approaches: early detection, early diagnosis, and early treatment. The World Health Organization (WHO) has clearly stated that early detection is key to improving cancer treatment rates. Early detection and diagnosis improve survival rates, and endoscopic biopsy is the "gold standard" for confirmation.

However, the penetration rate of endoscopic screening for digestive tract diseases in China is extremely low, with early diagnosis rates for digestive tract cancers less than 10%, compared to 70% and 55% in Japan and South Korea, respectively.

On April 13, 2018, the "National Digestive Tract Tumor Screening and Early Diagnosis and Treatment Plan" was officially launched. After the launch of the project, it is planned to screen 10 to 20 million people annually, and it is planned to rely on screening to achieve a 20% increase in the early diagnosis rate of gastrointestinal cancer and a 50% increase in the 5-year survival rate of gastrointestinal cancer by 2030. With the popularization of early gastrointestinal cancer screening and the implementation of new endoscopic techniques, the flexible endoscope market is entering a golden period of development.

Statistics show that the sales volume of the Chinese flexible endoscope market was approximately 2.87 billion yuan in 2015 and approximately 5.34 billion yuan in 2019, with a compound annual growth rate of approximately 16.79% from 2015 to 2019.

In addition, with the continuous maturity of minimally invasive surgery and the tiered medical treatment driving the improvement of endoscopy penetration rate in primary-level markets, the domestic flexible endoscope market will continue to maintain rapid growth in the future,and sales are expected to reach 8.12 billion yuan by 2025.

Source: Guoyuan Securities Research Institute

The market outlook is positive, but foreign companies have been developing for a longer time, with mature and rich technical accumulation and a complete sales and after-sales system, while domestic companies have a significant gap. Currently,Japanese companies represented by Olympus, Fujifilm, and Pentax Medical account for over 90% of the market share, with Olympus alone accounting for over 80%.

In the flexible endoscope field, the two largest domestic companies are currently Auhua Endoscopy and Kailite Medical. Auhua's domestic market share is less than 5%, ranking first among domestic brands.

This information is from the internet. Please contact us to delete it if there is any infringement.